切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2020, Vol. 09 ›› Issue (02) : 144 -149. doi: 10.3877/cma.j.issn.2095-3224.2020.02.007

所属专题: 文献

论著

洛铂用于结直肠癌术中腹腔灌注化疗的药代动力学研究
张睿1, 石刚1, 杨世华1, 苏昊2, 周思成2, 裴炜2, 梁建伟2, 刘正2, 关旭2, 赵志勋2, 刘骞2, 周志祥2, 王锡山2, 张景3,(), 周海涛2,()   
  1. 1. 110042 沈阳,辽宁省肿瘤医院结直肠外科
    2. 100021 北京,国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院结直肠外科
    3. 100122 北京市朝阳区桓兴肿瘤医院腹部外科
  • 收稿日期:2019-08-17 出版日期:2020-04-25
  • 通信作者: 张景, 周海涛
  • 基金资助:
    中国癌症基金会北京希望马拉松基金(No.LC2016B10); 中国医学科学院医学与健康科技创新工程(协同创新团队项目)(No.2017-I2M-4-002); 北京协和医学院2018年度研究生创新基金项目(No.2018-1002-02-26)

The study on Lobaplatin pharmacokinetics of intraoperative intraperitoneal perfusion chemotherapy in colorectal cancer

Rui Zhang1, Gang Shi1, Shihua Yang1, Hao Su2, Sicheng Zhou2, Wei Pei2, Jianwei Liang2, Zheng Liu2, Xu Guan2, Zhixun Zhao2, Qian Liu2, Zhixiang Zhou2, Xishan Wang2, Jing Zhang3,(), Haitao Zhou2,()   

  1. 1. Department of Colorectal Surgery, Liaoning Cancer Hospital&Institute, Shenyang 110042,China
    2. Department of Colorectal Surgery, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China
    3. Department of Abdominal Surgery, Cancer Hospital of HuanXing Chaoyang District Beijing, Beijing 100122, China
引用本文:

张睿, 石刚, 杨世华, 苏昊, 周思成, 裴炜, 梁建伟, 刘正, 关旭, 赵志勋, 刘骞, 周志祥, 王锡山, 张景, 周海涛. 洛铂用于结直肠癌术中腹腔灌注化疗的药代动力学研究[J/OL]. 中华结直肠疾病电子杂志, 2020, 09(02): 144-149.

Rui Zhang, Gang Shi, Shihua Yang, Hao Su, Sicheng Zhou, Wei Pei, Jianwei Liang, Zheng Liu, Xu Guan, Zhixun Zhao, Qian Liu, Zhixiang Zhou, Xishan Wang, Jing Zhang, Haitao Zhou. The study on Lobaplatin pharmacokinetics of intraoperative intraperitoneal perfusion chemotherapy in colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2020, 09(02): 144-149.

目的

研究洛铂用于预防性结直肠癌术中腹腔灌洗化疗过程中的药代动力学变化规律,为临床治疗提供参考依据。

方法

将含有120 mg/L浓度的洛铂溶液,在结直肠癌手术结束时灌入患者盆腹腔中,采集不同时点静脉血及腹腔引流液,应用LC_MS/MS方法,测定洛铂在血液和腹腔引流液中各时点药物浓度。

结果

11例患者灌注洛铂后0 h,0.5 h,l h,2 h,3 h,4 h,6 h,10 h,24 h,检测静脉血中洛铂的平均药物浓度分别为(333.50±333.00)ng/mL,(428.40±321.98)ng/mL,(425.90±347.70)ng/mL,(318.20±291.92)ng/mL,(198.90±196.85)ng/mL,(158.40±186.53)ng/mL,(68.90±66.06)ng/mL,(21.50±19.10)ng/mL,(6.70±0.00)ng/mL;腹腔引流液中洛铂的平均药物浓度分别为(62 940.20±29 786.14)ng/mL,(58 635.50±29 220.12)ng/mL,(50 559.60±27 661.24)ng/mL,(23 873.90±20 655.82)ng/mL,(15 440.80±19 075.12)ng/mL,(14 382.20±21 208.10)ng/mL,(12 929.70±20 245.06)ng/mL,(10 775.30±19 995.77)ng/mL,(64.00±111.93)ng/mL。洛铂在结直肠癌患者血浆中药动学符合二室模型拟合,各药动学参数分别为:最大血药浓度Cmax为(532.65±383.76)ng/mL,消除半衰期(t1/2z)为(1.84±0.32)h,药-时曲线下面积AUC(0-t)为(1 788.402±1 543.580)h?ng/mL;引流液中洛铂最大药物浓度Cmax为(69 055.0±27 587.55)ng/mL,消除半衰期(t1/2z)为(5.994±8.397)h;药-时曲线下面积AUC(0-t)为(257 421.876±288 148.148)h?ng/mL。

结论

洛铂腹腔灌洗化疗在腹腔中可持久维持较高的有效药物浓度,且血液吸收少,从而副作用较少,安全可靠,值得进一步研究。

Objective

To study the pharmacokinetics of Lobaplatin in the course of intraoperative intraperitoneal perfusion chemotherapy in colorectal cancer.

Methods

Poured the lobaplatin solution with120 mg/L into the pelvic and abdominal cavity after operation, Collected venous blood and its abdominal drainage fluid at different time points. LC_MS/MS method was used to determine the drug concentration of Lobaplatin in blood and abdominal drainage fluid.

Results

The mean concentrations of lobaplatin at 0 h, 0.5 h, 1 h, 2 h, 3 h, 6 h, 10 h and 24 h after infusion were (333.50±333.00) ng/mL, (428.40±321.98) ng/mL, (425.90±347.70) ng/mL, (318.20±291.92) ng/mL, (198.90±196.85) ng/mL, (158.40±186.53) ng/mL, (68.90±66.06) ng/mL, (21.50±19.10) ng/mL, (6.70±0.00) ng/mL, respectively. the mean concentration in the celiac drainage was (62 940.20±29 786.14) ng/mL, (58 635.50±29 220.12) ng/mL, (50 559.60±27 661.24) ng/mL, (23 873.90±20 655.82) ng/mL, (15 440.80±19 075.12) ng/mL, (14 382.20±21 208.10) ng/mL, (129 29.70±20 245.06) ng/mL, (10 775.30±19 995.77) ng/mL, (64.00±111.93) ng/mL. The pharmacokinetics of Lobaplatin accords with two-compartment model fitting in the pharmacokinetics of plasma traditional Chinese medicine in patients with colorectal cancer. The pharmacokinetic parameters were as follows: the maximum plasma concentration (Cmax) was (532.65±383.76) ng/mL, the elimination half-life (t1/2z) was (1.84±0.32) h, and the area AUC (0-t) under the drug-time curve was (1 788.402±1 543.580) h?ng/mL. The maximum drug concentration in the drainage solution was (69 055.0±27 587.55) ng/mL, the elimination half-life (t1/2z) was (5.994±8.397) h, and the area AUC (0-t) under the drug-time curve was (257 421.876±288 148.148) h?ng/mL.

Conclusion

Lobaplatin intraperitoneal irrigation chemotherapy can maintain a high effective drug concentration in the abdominal cavity with less blood absorption, and fewer side effects, which can be used as an effective treatment method to prevent metastasis of colorectal cancer.

图1 11名结直肠癌患者接受洛铂给药后血浆平均药-时曲线
表1 洛铂给药后血浆和引流液药代动力学参数
图2 11名结直肠癌患者接受洛铂给药后引流液平均药-时曲线
[1]
Chen W, Zheng R, Baade PD, et al. Cancer Statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2]
Papanikolaou IG. Robotic surgery for colorectal cancer: systematicreview of the literature [J]. Surg Laparosc Endosc Percutan Tech, 2014, 24(6): 478-483.
[3]
Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer [J]. Lancet, 2010, 375(9719): 1030-1047.
[4]
Jayne DG, Fook S, Loi C, et a1. Peritoneal careinomatosis from colorectal cancer [J]. Br J Surg, 2002, 89(12): 1545-1550.
[5]
Teo M. Peritonealbased malignancies and their treatment [J]. Ann Acad Med, 2010, 39(1): 54-57.
[6]
Elias D, Glehen O, Pocard M, et a1. A comparative study of complete cytoreduetive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon,rectum,small bowel,and no pseudomyxoma appendix [J]. Ann Surg, 2010, 251(5): 896-901.
[7]
中国医师协会结直肠肿瘤专业委员会.结直肠癌术中腹腔化疗专家意见(2017版) [J/CD]. 中华结直肠疾病电子杂志, 2017, 6(6): 442-446.
[8]
白雪, 于波, 苑树俊, 等. 洛铂和奥沙利铂对结直肠癌细胞系生物学行为影响的实验研究[J]. 临床肿瘤学杂志, 2009, 1(14): 690-693.
[9]
周宏峰, 张玉新, 程黎阳, 等.洛铂、氟尿嘧啶与亚叶酸钙联合化疗的临床毒副作用[J]. 世界华人消化杂志, 2007, 15(1): 86-87.
[10]
周宏峰, 张玉新, 吴良平, 等.洛铂与草酸铂在联合化疗方案中毒副作用的比较[J]. 世界华人消化杂志, 2008, 16(2): 225-227.
[11]
林丽珠, 周岱翰, 郑心婷.洛铂联合氟尿嘧啶和甲酰四氢叶酸治疗晚期耐药胃癌结直肠癌疗效观察[J]. 中国肿瘤临床, 2007, 34(5): 286-288.
[12]
刘思海, 冯雯, 朱瑞霞, 等.洛铂和草酸铂分别联合替加氟及卡培他滨治疗晚期大肠癌的比较研究[J]. 中华肿瘤防治杂志, 2008, 15(23): 1830-1834.
[13]
赵海波.大肠癌根治术后静脉化疗联合腹腔化疗疗效分析[J]. 当代医学, 2009, 15(1): 80-81.
[14]
史健, 袁志芳, 刘伟娜, 等.国产注射用洛铂在恶性肿瘤患者体内药动学的研究[J]. 中国药学杂志, 2007, 42(24): 1888-1891.
[15]
Gietema JA, de Vries EG, Sleijfer DT, et a1. A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days [J]. Br.J.Cancer, 1993, 67(2): 396-401.
[16]
Gietema JA, Veldhuis GJ, Guchelaar HJ, et a1. PhaseⅡ and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer [J]. British Joumal of Cancer, 1995, 71(6): 1302-1307.
[17]
史健, 袁志芳, 刘伟娜, 等.国产注射用洛铂在恶性肿瘤患者体内药动学的研究[J]. 中国药学杂志, 2007, 42(24): 1888-1891.
[1] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[8] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9] 孙一娇, 包润发, 董平, 束翌俊. PBL结合手术视频剪辑教学在普通外科专科医师规范化培训中的应用与思考[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 96-99.
[10] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[11] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[12] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[13] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[14] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[15] 张耕毓, 唐冲, 张昆, 张辉, 张清华, 刘家帮. 股骨头坏死髓芯减压术的文献计量学分析及单中心病例报道[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 771-780.
阅读次数
全文


摘要